Gain Therapeutics Stock Cycle Indicators Hilbert Transform Dominant Cycle Phase
| GANX Stock | USD 1.72 0.10 6.17% |
| Symbol |
Indicator |
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Hilbert Transform - Dominant Cycle Phase indicator shows inphase and quadrature components of Gain Therapeutics price series in order to analyze variations of the instantaneous phase and amplitude.
Gain Therapeutics Technical Analysis Modules
Most technical analysis of Gain Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Gain from various momentum indicators to cycle indicators. When you analyze Gain charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Gain Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Gain Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gain Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Gain Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gain Therapeutics's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Gain Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Gain Therapeutics, we also check how macroeconomic factors affect Gain Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Payables Turnover | 8.63 | 4.76 | Days Of Inventory On Hand | 197.37 | 175.44 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gain Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gain Therapeutics' short interest history, or implied volatility extrapolated from Gain Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Macroaxis Picks Invested over 40 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
 | Momentum Invested few shares |
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.